P/E ratio for ChemoMetec (CHEMM.CO)
P/E ratio at the end of 2022: 84.2
According to ChemoMetec's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 31.7437. At the end of 2022 the company had a P/E ratio of 84.2.
P/E ratio history for ChemoMetec from 2007 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 84.2 | -43.5% |
| 2021 | 149 | 74.3% |
| 2020 | 85.5 | 54.49% |
| 2019 | 55.3 | 16.45% |
| 2018 | 47.5 | -26.67% |
| 2017 | 64.8 | 35.29% |
| 2016 | 47.9 | 52.15% |
| 2015 | 31.5 | -24.7% |
| 2014 | 41.8 | -73.12% |
| 2013 | 156 | -2690% |
| 2012 | -6.01 | -101.58% |
| 2011 | 379 | -1893.47% |
| 2010 | -21.1 | -160.41% |
| 2009 | 35.0 | 88.05% |
| 2008 | 18.6 | -90.61% |
| 2007 | 198 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.